نتائج البحث - "Benjamin M. Ellingson"

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 23, iss 19
Clinical Cancer Research, 23(19), 5745-5756. American Association for Cancer Research Inc.

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Male, Oncology, Cancer Research, Imaging biomarker, Pyridines, Phases of clinical research, Angiogenesis Inhibitors, chemistry.chemical_compound, 0302 clinical medicine, Lomustine, Receptors, Medicine, Anilides, Cancer, Aflibercept, Tumor, Vascular Endothelial Growth Factor, Middle Aged, Bevacizumab, Local, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Biomedical Imaging, Female, medicine.drug, medicine.medical_specialty, Cabozantinib, Recombinant Fusion Proteins, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Article, Disease-Free Survival, Cediranib, 03 medical and health sciences, Rare Diseases, Clinical Research, Internal medicine, Biomarkers, Tumor, Humans, Effective diffusion coefficient, Oncology & Carcinogenesis, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, Brain Disorders, Brain Cancer, Receptors, Vascular Endothelial Growth Factor, Neoplasm Recurrence, Diffusion Magnetic Resonance Imaging, chemistry, Quinazolines, Neoplasm Recurrence, Local, Glioblastoma, business, Nuclear medicine, Biomarkers, 030217 neurology & neurosurgery

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8bba073dc3ce7c7331b542d1e654786Test
https://doi.org/10.1158/1078-0432.ccr-16-2844Test

6

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

المؤلفون: Patrick Y. Wen, Whitney B. Pope, Colin Hessel, Davis C. Woodworth, Gisela Schwab, Phioanh L. Nghiemphu, Robert J. Harris, Lauren E. Abrey, Solmaz Sahebjam, Warren P. Mason, Timothy F. Cloughesy, Albert Lai, Dana T. Aftab, Kevin Leu, Benjamin M. Ellingson, Okkar Zaw

المصدر: Neuro-oncology, vol 19, iss 1
Ellingson, BM; Harris, RJ; Woodworth, DC; Leu, K; Zaw, O; Mason, WP; et al.(2017). Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single-and multicenter trials. NEURO-ONCOLOGY, 19(1), 89-98. doi: 10.1093/neuonc/now187. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7xr4b3kdTest

مصطلحات موضوعية: Male, Oncology, Cancer Research, Contrast Media, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Cancer, Univariate analysis, Tumor, Brain Neoplasms, Middle Aged, Prognosis, Tumor Burden, Molecular Imaging, Bevacizumab, Survival Rate, Editorial, Local, 030220 oncology & carcinogenesis, Female, medicine.drug, medicine.medical_specialty, Cabozantinib, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Context (language use), bevacizumab, Irinotecan, Necrosis, 03 medical and health sciences, recurrent, Rare Diseases, cabozantinib, Clinical Research, Internal medicine, Biomarkers, Tumor, medicine, Humans, Oncology & Carcinogenesis, Survival rate, Neoplasm Staging, Retrospective Studies, T1 subtraction, business.industry, glioblastoma, Neurosciences, Retrospective cohort study, Brain Disorders, Surgery, Brain Cancer, Clinical trial, Neoplasm Recurrence, chemistry, tumor volume, Camptothecin, Neurology (clinical), Neoplasm Recurrence, Local, Glioblastoma, business, Biomarkers, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2decfa02dc8d2dd10f659b0e8ed53357Test
https://doi.org/10.1093/neuonc/now187Test

7

Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden

المؤلفون: Laura Dovek, Timothy F. Cloughesy, Myung-Shin Sim, Albert Lai, Arliene Ravelo, Huy Tram N. Nguyen, Liang Yen Liu, Robert Harris, Byram Ozer, Daniel Lenchner, Richard M. Green, Nhung T Nguyen, Robert Elashoff, Benjamin M. Ellingson, Nicolas Sommer, Phioanh L. Nghiemphu

المصدر: Neuro-oncology practice, vol 6, iss 2

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5eb25c25c268ce6c066359814f88fcdTest
https://escholarship.org/uc/item/03j1n5pdTest

8

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

المؤلفون: Ryo Nishikawa, Lauren E. Abrey, Robert J. Harris, Benjamin M. Ellingson, Roger Henriksson, Ararat Chakhoyan, Wolfgang Wick, Catalina Raymond, Olivier Chinot, Kevin Leu, Timothy F. Cloughesy, Josep Garcia, Arnav Mehta, Warren Mason, Davis C. Woodworth, Frank Saran, Whitney B. Pope

المساهمون: Institut de neurophysiopathologie (INP), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Ellingson, BM; Abrey, LE; Garcia, J; Chinot, O; Wick, W; Saran, F; et al.(2018). Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. NEURO-ONCOLOGY, 20(11), 1525-1535. doi: 10.1093/neuonc/noy064. UCLA: Retrieved from: http://www.escholarship.org/uc/item/1c51c6bdTest
Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2018, ⟨10.1093/neuonc/noy064⟩
Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy064⟩
Neuro-oncology, vol 20, iss 11

مصطلحات موضوعية: Male, Oncology, Cancer Research, [SDV]Life Sciences [q-bio], law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, 80 and over, ComputingMilieux_MISCELLANEOUS, Cancer, Aged, 80 and over, response assessment, medicine.diagnostic_test, Brain Neoplasms, Chemoradiotherapy, Middle Aged, Prognosis, Magnetic Resonance Imaging, Tumor Burden, Bevacizumab, Survival Rate, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Female, 4.2 Evaluation of markers and technologies, medicine.drug, MRI, Adult, medicine.medical_specialty, Adolescent, Oncology and Carcinogenesis, Clinical Investigations, Newly diagnosed, bevacizumab, Placebo, GBM, Young Adult, 03 medical and health sciences, Rare Diseases, Double-Blind Method, Clinical Research, Internal medicine, Temozolomide, medicine, Humans, Oncology & Carcinogenesis, Survival rate, Aged, clinical trials, business.industry, T1 subtraction, Neurosciences, glioblastoma, Magnetic resonance imaging, Brain Disorders, Brain Cancer, Clinical trial, Neurology (clinical), Glioblastoma, business, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6bd15c9d5ce9e742e59326a3e480bfTest
http://www.escholarship.org/uc/item/1c51c6bdTest

9

Phase II trial of bevacizumab and temozolomide for treatment of elderly patients with newly diagnosed glioblastoma

المؤلفون: Jonathan Polikoff, Fabio M. Iwamoto, William H. Yong, Donna Molaie, Mei Leng, Richard M. Green, Emese Filka, Thien Nguyen, Liz Spier, Hye Hyun Bahng, Benjamin M. Ellingson, Andrew B. Lassman, Albert Lai, Timothy F. Cloughesy, Stacey Green, Whitney B. Pope, Phioanh L. Nghiemphu

المصدر: Journal of Clinical Oncology. 38:2540-2540

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Temozolomide, Bevacizumab, business.industry, medicine.medical_treatment, Newly diagnosed, medicine.disease, Surgery, law.invention, Radiation therapy, Randomized controlled trial, law, Internal medicine, medicine, business, medicine.drug, Glioblastoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0aaf16e96884e7036e62dca495d48efbTest
https://doi.org/10.1200/jco.2020.38.15_suppl.2540Test

10

NIMG-47. VOLUMETRIC ANALYSIS OF PHASE 2 AND 3 TRIALS IN RECURRENT GLIOBLASTOMA TREATED WITH VB-111 WITH OR WITHOUT BEVACIZUMAB OR BEVACIZUMAB MONOTHERAPY

المؤلفون: Nicholas Butowski, Catalina Raymond, Dror Harats, Jodi Goldman, Andrew Brenner, Yael Cohen, Patrick Y. Wen, Benjamin M. Ellingson, Jacob Schlossman, Timothy F. Cloughesy, Jingwen Yao, Tamar Rachmilewitz Minei, Caleb Tran

المصدر: Neuro Oncol

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, business.industry, Internal medicine, Recurrent glioblastoma, Neuro-Imaging, medicine, Neurology (clinical), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add0f8215238eadb4dab18efdd1f1429Test
https://doi.org/10.1093/neuonc/noz175.717Test

تنقيح النتائج